AU6392496A - The combination of topical nasal antihistamines and topical nasal steroids - Google Patents
The combination of topical nasal antihistamines and topical nasal steroidsInfo
- Publication number
- AU6392496A AU6392496A AU63924/96A AU6392496A AU6392496A AU 6392496 A AU6392496 A AU 6392496A AU 63924/96 A AU63924/96 A AU 63924/96A AU 6392496 A AU6392496 A AU 6392496A AU 6392496 A AU6392496 A AU 6392496A
- Authority
- AU
- Australia
- Prior art keywords
- topical nasal
- combination
- antihistamines
- steroids
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000699 topical effect Effects 0.000 title 2
- 229940125715 antihistaminic agent Drugs 0.000 title 1
- 239000000739 antihistaminic agent Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US496814 | 1990-03-20 | ||
| US49681495A | 1995-06-29 | 1995-06-29 | |
| PCT/US1996/010789 WO1997001337A1 (en) | 1995-06-29 | 1996-06-25 | The combination of topical nasal antihistamines and topical nasal steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6392496A true AU6392496A (en) | 1997-01-30 |
Family
ID=23974249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63924/96A Abandoned AU6392496A (en) | 1995-06-29 | 1996-06-25 | The combination of topical nasal antihistamines and topical nasal steroids |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6392496A (en) |
| WO (1) | WO1997001337A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2256721A1 (en) * | 1996-06-04 | 1997-12-11 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
| SE9604486D0 (en) | 1996-12-05 | 1996-12-05 | Astra Ab | Novel formulation |
| FR2756739B1 (en) | 1996-12-05 | 2000-04-28 | Astra Ab | NEW BUDESONIDE FORMULATION |
| CN1253508A (en) * | 1997-04-30 | 2000-05-17 | 沃尼尔-朗伯公司 | Topical nasal anti-inflammatory composition |
| EP1788816A3 (en) | 1997-11-05 | 2008-10-15 | Sony Corporation | Transform domain interpolation for resolution conversion of coded video data |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| US6712803B1 (en) * | 1999-08-11 | 2004-03-30 | Howard Paritsky | Drug dispensing system |
| DE19947234A1 (en) * | 1999-09-30 | 2001-04-05 | Asta Medica Ag | New combination of loteprednol and antihistamines |
| AR026073A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE |
| AR026072A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION |
| DK1467762T3 (en) * | 2001-12-05 | 2006-04-10 | Alcon Inc | Use of an H1 antagonist and rimexolone as a safe steroid for the treatment of rhinitis |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| ATE472329T1 (en) | 2002-08-30 | 2010-07-15 | Nycomed Gmbh | USE OF THE COMBINATION OF CICLESONIDE AND ANTHISTAMINICS FOR THE TREATMENT OF ALLERGIC RHINITIS |
| BR0316203A (en) * | 2002-11-12 | 2005-10-04 | Alcon Inc | Use of an antiallergic agent and a steroid to treat allergic rhinitis |
| US20050026887A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a steroid |
| WO2005030331A1 (en) * | 2003-09-26 | 2005-04-07 | Fairfield Clinical Trials, Llc | Combination antihistamine medication |
| WO2005037245A2 (en) * | 2003-10-21 | 2005-04-28 | Direct-Haler A/S | A multiple route medication for the treatment of rhinitis and asthma |
| US20050255154A1 (en) | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| DK2377557T3 (en) | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
| EP1868578A2 (en) | 2005-03-23 | 2007-12-26 | Elan Pharma International Limited | Nanoparticulate corticosteroid and antihistamine formulations |
| ATE534390T1 (en) * | 2007-11-19 | 2011-12-15 | Bausch & Lomb | USE OF LEVOCABASTINE TO MODULATE PROINFLAMMATORY CYTOKINES GENERATION |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| KR101261230B1 (en) | 2010-11-29 | 2013-05-07 | 한림제약(주) | Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| CN107737105A (en) * | 2017-11-28 | 2018-02-27 | 贵州云峰药业有限公司 | A kind of nasal cavity agent of azelastine hydrochloride composition spray and production technology |
-
1996
- 1996-06-25 AU AU63924/96A patent/AU6392496A/en not_active Abandoned
- 1996-06-25 WO PCT/US1996/010789 patent/WO1997001337A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997001337A1 (en) | 1997-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6392496A (en) | The combination of topical nasal antihistamines and topical nasal steroids | |
| AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
| AU6046396A (en) | Tricot-like pouch for the delivery of topical drugs and cosm etics | |
| AU3003295A (en) | Improved inhaler and medicated package | |
| AU1426995A (en) | Local delivery and monitoring of drugs | |
| AU7710198A (en) | Single pass lead and method of use | |
| AU1021997A (en) | Cd100 antigen and uses therefor | |
| AU3280297A (en) | Nasal administration of desmopressin | |
| AU4463996A (en) | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof | |
| AU6840298A (en) | Cosmetic or dermatological use of 7-hydroxylated steroids | |
| AU7143896A (en) | Heat-removable bandage and medical tape | |
| AU2438695A (en) | Therapeutic phenoxyalkylpyridazines and intermediates therefor | |
| AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
| AU6318896A (en) | Benzamidoxime derivatives and medicinal use thereof | |
| AU2512495A (en) | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | |
| AUPN104895A0 (en) | Methods of and preparations for the treatment of ailments and disorders | |
| AU6177994A (en) | System for the protection of people and/or property | |
| AU6290396A (en) | The combination of topical nasal mast cell stabilizers and topical nasal steroids | |
| AU3479495A (en) | Alpha-1-antitrypsin and antithrombine-iii variants | |
| AU7638096A (en) | An envelope and envelope construction | |
| AU6181196A (en) | The combination of topical nasal antihistamines and topical nasal mast cell stabilizers | |
| AU2154695A (en) | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof | |
| AU4244593A (en) | Pentacyclic antihistamines | |
| AU4552496A (en) | Screeding devices and methods of use | |
| AU1921797A (en) | Gate for the passage of people |